NASDAQ:CKPT
Checkpoint Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.checkpointtx.comipo date
Dec 19, 2016
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1...Show More
Earnings
Earnings Release in 17 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus